Delivery Order SPE2DB20D2014-SPE2DB24FB89D
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,059.34 firm fixed price delivery order is for the supply of 4,565,014,822 units of 250 mg erythromycin tablets. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,721.42 firm fixed-price delivery order contract is for the supply of 100 units of Erythromycin 250 mg tablets. The contract has an ultimate completion date of July 2, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $17,991.36 firm fixed price delivery order is for the supply of 100 count bottles of 250mg Erythromycin tablets. The contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, as the prime contractor. The award is for the delivery of Erythromycin 250 mg tablets, with a potential value of $4,159.09 and a completion date of February 2, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is also the prime contractor on a larger...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued at $1,314.77, is for the delivery of 4,565,477,781 Erythromycin 250 mg tablets in quantities of 100s. The contract is a firm fixed-price Delivery Order with an ultimate completion date of August 19, 2024. Amerisourcebergen is a major pharmaceutical distributor and has been awarded multiple Indefinite Delivery Contracts...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,329.00 firm fixed price delivery order is for the supply of 4565154032 - Erythromycin 250 MG Tablet 30s, with a completion date of July 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $2,598.65 firm fixed-price delivery order is for the supply of 4565333269 - Erythromycin 250 mg tablets, 100 count. The contract has an ultimate completion date of August 5, 2024 and does not utilize a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,562,539 Erythromycin 500 mg tablets. The fixed-price delivery order, valued at $2,994.60, has an ultimate completion date of October 20, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $2,248.92, is for the supply of 4565862416 - Erythromycin 250 mg Tablets (100 count) to support military treatment facilities and healthcare programs. The contract has a Firm Fixed Price pricing type and an ultimate completion date of September 19, 2024. Amerisourcebergen, a major pharmaceutical distributor,...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,979.79 firm fixed price delivery order is for the supply of 4,567,675,485 tablets of 250 mg Erythromycin. The contract has an ultimate completion date of March 25, 2025 and was awarded on March 24, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB89DDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,969.92 firm fixed price delivery order is for the supply of 4564589786 - Erythromycin DR 250 mg Tablets in quantities of 30s. The contract has an ultimate completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. The contract award was made on a full and open competition basis without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 5/13/24 |